Serial Number | 98189228 |
Word Mark | REJUVXL |
Filing Date | Wednesday, September 20, 2023 |
Status | 645 - FINAL REFUSAL - MAILED |
Status Date | Wednesday, March 26, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Cell therapy preparation in the nature of cells for medical and clinical use; cell therapy preparation in the nature of cryopreserved cells for medical and clinical use; cell therapy preparation in the nature of cell suspension being living cells for medical and clinical use; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells for injection for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells, for infusion for medical and clinical use for treating kidney disease; cell therapy preparation in the nature of pharmaceutical preparations, namely, living cells for treating chronic diseases such as chronic kidney disease, inflammatory diseases such as lung disease, immune-mediated conditions such as autoimmune disease or graft-versus-host disease, degenerative diseases such as neurodegenerative diseases; cell therapy preparation in the nature of cell clusters being living cells clusters for medical and clinical use; cell therapy preparation in the nature of tissue being biological tissue cultures for medical and clinical use; therapeutic preparation in the nature of cell derivatives being biological materials derived from cells, namely extracellular vesicles, secretome, conditioned media, soluble factors, membrane fragments, or extracellular matrix for medical and clinical use; cell therapy preparation in the nature of pharmaceutical preparations comprised of molecules for combination with cell therapy for medical and clinical use for treating kidney disease; cell therapy preparation in the nature of pharmaceutical preparations comprised of molecules for combination with cells for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation in the nature of pharmaceutical preparations comprised of supramolecular complexes in combination with cells for medical and clinical use for treating chronic, inflammatory, or immune-mediated conditions; cell therapy preparation of cell components being mitochondria or vesicles for medical and clinical use |
Goods and Services | Cell therapy preparation in the nature of cells for development use, other than for medical or veterinary purposes |
Goods and Services | Medical services; medical treatment using cultured cells; medical treatment protocol that includes administration of living cells; medical treatment, namely, injection of living cells for the treatment of chronic, inflammatory, or immune-mediated conditions; medical treatment, namely, infusion of living cells for the treatment of chronic, inflammatory, or immune-mediated conditions; medical treatment namely injection or infusion or implantation of living cells in combination with induction and or maintenance treatment with vitamins, protective molecules, and or pharmacological agents |
Goods and Services | Medical and scientific research and development in the field of cell therapy, regenerative medicine and healthspan medicine; cell therapy preparation in the nature of testing for research, development, engineering and testing services in the fields of immunopharmaceuticals, immunomodulators |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, March 4, 2025 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 6, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 6, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, October 6, 2023 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | AION Healthspan, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Miami, FL 33137 |
Event Date | Event Description |
Saturday, September 23, 2023 | NEW APPLICATION ENTERED |
Tuesday, May 14, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, May 14, 2024 | ASSIGNED TO EXAMINER |
Tuesday, May 14, 2024 | NON-FINAL ACTION E-MAILED |
Friday, October 6, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, May 14, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, May 16, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Thursday, May 16, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, May 16, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, May 31, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, May 31, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, May 31, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, June 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, July 9, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, July 9, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Tuesday, June 18, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Tuesday, July 9, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, July 9, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, August 14, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, August 14, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, August 14, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, September 4, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, November 27, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Wednesday, November 27, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Tuesday, March 4, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, March 4, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, September 4, 2024 | NON-FINAL ACTION E-MAILED |
Wednesday, September 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, March 4, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, March 10, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, March 10, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, March 26, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, March 26, 2025 | FINAL REFUSAL WRITTEN |
Wednesday, March 26, 2025 | FINAL REFUSAL E-MAILED |
Monday, March 10, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |